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The MHC-restricted TCR consists ofa 90-kD heterodimeric glycoprotein com-
posed ofan a and a(3 chain that are encoded by somatically rearranging gene seg-
ments (forreview, seereferences 1-3). Receptordiversity andantigen/MHC specificity
are generated byrearrangementoftheknownvariable elements (variable [V], diversity
[D], and joining [,J] segments), as well as by the addition ofN-region nucleotides.
While the a/(3 receptor confers both antigen recognition and MHC restriction (4,
5), no generalrules forthe relative contribution ofspecific variable elements to anti-
gen or MHC specificityhave emerged. Early work demonstrated that the same Va
andV(3 gene segments can encode areceptor with specificity for antigen plus aclass
II MHC gene product or with specificity for a class I alloantigen (6). The same V/3
domain has been shown to participate in a TCR specific for cytochrome c/1-Ek as
well as in a TCR reactive to hen eggwhite lysozyme/I-Ab (7). On the other hand,
surveys ofsperm whale myoglobin-reactive T cells (8) and ofcytochrome c-reactive
T cells (9, 10)have been consistent with the idea that the Va gene segment encodes
a TCR's antigen specificity while the Vodomain confers its MHC specificity. How-
ever, studies of additional cytochrome c-specific T cells have shown that in some
cases, the a chain influences the MHC specificity ofa particular TCR (11). Thus,
no simple correlation has emerged.
Even though it has been difficult to establish a precise relationship between a V
domain and apattern ofMHC restriction, TCR V region domains havebeen shown
to confer an affinity for MHC-encoded gene products. Blackman et al. (12) found
that the random pairing of a BW5147-derived a chain and a a chain derived from
a normal T cell generates an MHC-reactive (anti-Dd) TCR. Kappler et al. (13)have
shown that the participation ofthe V017a domain in aTCR predisposes to I-Ereac-
tivity and that T cells bearing V017a+ TCRs are eliminated in I-E+ strains ofmice
(14). Two other V(O elements (Va8.1 and V06) have been shown to confer broad
specificity to the Mls-la gene product (15-17). We report here the production ofan
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mAb, RR3-15, which recognizes TCRs encoded by the Vo11 gene segment. Using
this antibody, we find that, as with V017a+ T cells, T cells that express V/311-
encoded TCRs are eliminated in the thymus of I-E-expressing strains of mice. Sur-
prisingly, it has been difficult to demonstrate reactivity of T cells expressing Voll-
encoded antigen receptors for I-E molecules. Finally, experiments with B6 x DBA/2
recombinant inbred mice suggest that I-E expression is necessary but not sufficient
for the clonal elimination of Vo11+ T cells.
Materials and Methods
Mice.
￿
All mice were purchased from The Jackson Laboratories, Bar Harbor, ME, or
bred in the facilities of the National Jewish Center for Immunology and Respiratory Medi-
cine, Denver, CO. Fisher rats were purchased from The Jackson Laboratory.
Cell Lines and Antibodies.
￿
To generate the RR3-15 mAb, a Fisher rat received four bi-weekly
immunizations, each consisting of 2 x 107 OH6 cells, injected intraperitoneally. The cyto-
toxic T cell clone OH6 has been described previously (18). It was derived from C57BL/6
and is specific for H-Y in the context of H-2136. 1 mo after the fourth immunization, 2 x
107 OH6 cells were injected intravenously, and 3 d later, the rat was killed and its spleen
cells were fused to P3X63.Ag8.653 cells using established procedures. The hybridomas were
cultured in HATcontaining medium and supernatants from growing hybrids were assayed
as described (18). Briefly, culture supernatants were tested for their ability to facilitate lysis
of labeled P815 cells by the OH6 T cell clone. Lysis depends on the presence in the culture
supernatant of an antibody that can bridge target and killer cells by binding to the Fc recep-
tor on P815 target cells and to the TCR on cytotoxic OH6 cells. In this manner, the mAb
RR3-15 was identified.
The OH2 cytotoxic T cell clone and the mAb MR5-2 have been described (18). OH2
is also specific for H-136 plus the HY antigen. MR5-2 recognizes TCRs containing V08 .1
or 8.2, including the TCR of OH2, which contains V08.1 . The T cell hybrid KL was ob-
tained by fusing OH6 cells to the C58 rat thymoma as described (19). T cell hybrids K12
and K13 were generated by fusing Con A-stimulated T cell blasts from B10 .A(4R) to C58
as above. The resultant hybrids were panned using RR3-15-coated plates, and two hybrids
positive for surface staining with RR3-15 were obtained and cloned by limiting dilution.
Cytotoxicity Assays.
￿
Cytolytic activity was measured by the "'Cr release assay (20). Briefly,
104 "Cr-labeled P815 cells (100 kl) were added to dilutions of CTL cells in V-bottomed mi-
crotiter plates (100 wl) . After incubation at 37°C for 3.5 h, the plates were centrifuged and
100 gl of supernatant was collected for measurement of 5'Cr release.
Radioiodination and Immunoprecipitation.
￿
Cell surface proteins were labeled by lactoperoxi-
dase-catalyzed radioiodination, immunoprecipitated using RR3-15 or RR3-18 and Staphy-
lococcus protein A, and analyzed on one-dimensional SDS polyacrylamide gels under reducing
and nonreducing conditions as described (18).
Hybridization Analyses.
￿
Total cellular RNA was isolated by the method of Cheley and An-
derson (21) or by cell lysis in guanidine isothiocyanate and ultracentrifugation over a cesium
chloride cushion (22). 3 x 105 cell equivalents or 0.5 l~g of total cellular RNA were blotted
onto nitrocellulose filters that were hybridized with 32P-labeled probes for TCR variable re-
gion genes as described (23).
Immunofluorescent Staining.
￿
T cell hybrids, Thmocytes, and nylon wool-nonadherent lymph
node cells were analyzed for expression of RR3-15 using indirect immunofluorescent stain-
ing. The primary reagent was either culture supernatant or biotinylated RR3-15, and the
secondary reagent was fluorescein-conjugated goat anti-rat Fc (Rockland, Inc., Gilbertsville,
PA) or phycoerythrin conjugated with streptavidin (Becton Dickinson & Co., Mountain View,
CA), respectively. Thymocytes were precultured for 8 h in complete tumor medium (CTM)
at 5 x 106/ml to increase the level of TCR expression on the immature, cortical cells (14).
Thymocytes were preincubated with 5°Jo normal mouse serum (BALB/c) to reduce back-
ground. The level of I-Ed expression was measured on unfractionated lymph node cells using
a biotinylated mAb 14.4.4., followed by phycoerythrin-conjugated streptavidin as above. TheBILL ET AL
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presence of CD4 on T cell hybridomas was determined asing the mAb GKL5, followed by
goat anti-rat Fc as above. Samples were analyzed on an Epics C flow cytometer (Coulter
Electronics Inc., Hialeah, FL).
IL-2 Assays.
￿
T cell hybridomas were stimulated with cells or antibodies and the amount
of IL-2 released was measured using HT-2 indicator cells, as previously described (24).
Results
Generation ofthe RR-3-15 Antibody.
￿
We were interested in generating an mAb to
the antigen receptor on the cytolytic T cell clone OH-6. This clone is specific for
the male antigen, H-Y, and is Db restricted . Fisher rats were immunized with OH6
cells as described in Materials and Methods and spleen cells were fused with the
B cellhybridomafusion parent, P3X63Ag8.653. The supernatants from HATresistant
B cell hybridomas were tested for their ability to mediate lysis oflabeled P815 cells
by cytolytic OH6 T cells, as described previously (18, 25, 26). The principle ofthis
assay is that an antiTCR mAb can bridge TCR-bearing OH6 cells with Fc
receptor-bearing P815 cells and mediate lysis of the P815 cells, even though P815
cells do not bear the nominal antigen recognized by the OH6 cell line. The sensi-
tivity ofthe assay resides in the fact that antiTCR and anti-CD3 mAbs are highly
efficient at activating the cytolytic T cells to kill P815. Similar activation with anti-
Thy-1 mAbs, forexample, requires much higher antibody concentrations (data not
shown).
Using this assay, we identified a B cell hybridoma producing the mAb RR3-15 .
This mAb reproducibly mediates the killingofP815 cells by the immunizingclone,
OH6, and the specificity of this antibody is demonstrated by the data in Table I.
RR3-15 mediates the killing of P815 by OH6 but not by unrelated OH2 cells. On
the other hand, the anti-V,38 mAb, MR5-2, mediates the killing of P815 by OH2
butnot by OH6cells. Thus, theRR3-15 antibody is specific for adeterminantpresent
on OH6 but absent from OH2 cells. That this antibody recognizes a determinant
on the OH6 TCR is shown in Fig. 1. Lysates ofradiolabeled surface proteins from
OH6 cells were subjected to precipitation withthe RR3-15 mAb and Staphylococcus
proteinA. Precipitated proteins were analyzed by SDS-PAGEand autoradiography.
The major precipitated protein under nonreducing conditions (without 2-ME) is
TABLE I
Cytolytic Activity of OH2 and OH6 on P815 Cells
OH6 and OH2 are cytotoxic T cell clones specific for H-Y/H-2Db. MR5-2 is
an mAb specific for TCR variable regions V138.1 and V08.2 . In the absence
ofnominal antigen, lysis ofP815 cells results from bridging by anti-TCR mAbs
of P815 cells via Fc receptors and T cell clones via their TCR.
E/T ratio
Antibody 30 10 3 1
OH6 None 2 1 2 2
MR5-2 1 2 3 2
RR3-15 56 52 58 40
OH2 None 4 4 2 1
(V08 .1) MR5-2 47 37 36 28
RR3-15 7 6 4 31408
￿
I-E IS NECESSARY BUT NOT ADEQUATE FOR T CELL TOLERANCE
FIGURE 1 .
￿
RR3-15 precipitates TCR
from theT cell clone OH6 .SDS-PAGE
analysis ofsurface-labeled proteins im-
munoprecipitated from theOH6T cell
clone . Lane 1, immunoprecipitation
with RR3-15 ; lane 2, immunoprecipi-
tation with RR3-18, an anticlonotypic
mAb specific for the TCR ofOH6.
Gels were rununder nonreducing con-
ditions(-2-ME)orunder reducingcon-
ditions (+2-ME).
a 90-kD species that appears as a 43-kD species under reducing conditions (with
2-ME) . This is characteristic of the disulfide-linked heterodimeric, (a/a) antigen
receptoronTcells . The data in Fig. 1 also show that a similar protein can be precipi-
tated from OH-6 cells using an anticlonotypic antibody, RR3-18 .
The Determinant Recognized by the RR3-15 mAb Is Encoded by the V011 Gene Seg-
ment . Cytofluorographic analysis demonstrated that the determinant detected by
the RR3-15 mAb is present on ti5% ofC57BL/10 peripheralT cells but on an un-
detectable fraction ofSWRand C57L peripheral T cell (Table II) . SinceSWRand
C57L mice carry an allele of the /3 chain gene complex that has deleted the V05,
V08, V09, Va11, V012, andV013 structural genes (27, 28), we considered thepossi-
bility that the RR3-15 mAb recognizes a determinant encoded by one of these gene
segments . We had available to us a large collection of random T cell hybridomas
in which we had determined the expression of particular Va andVii gene segments
by hybridization analysis of hybridoma RNA (23) ; the data in the lower portion
of Table III demonstrates that none of the 10 hybridomas expressing the V/35, V08,
V09, V012, or V013 gene segments expressed theepitope recognized by theRR3-15
mAb. In contrast, 31 of 39 hybrids that were shown to express VR1l RNA express
the RR3-15 determinant . The hybridomas that express the RR3-15 epitope coex-
press avarietyof differentVa gene families . Therefore, it seems likely that the RR3-
15 determinant is encoded by the V011 gene segment, and its expression is not de-
pendenton the presence of particularVQyJa, Dpi, orJ/3 gene segments . This is similar
to other mAbs with reactivity for other v(3 gene products (13, 16, 17, 26, 29, 30) .
The eight hybrids expressingV011 RNA but not the RR3-15 determinant probablyBILL ET AL.
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TABLE If
Expression of V,611 + T Cells in Various Mouse Strains
VOI I expression is determined by immunofluorescent staining with RR3-15 as
described in Materials and Methods. H-2 genotype for recombinant loci is indi-
cated according to chromosomal position relative to the centromere ofchromo-
some 17 (K, I-Aa,I-Ace, I-E/3, I-Ea, D). For most strains, at least three mice
were examined and the mean value ± SEM is given. For strains where only
one or two mice were examined, the individual values are given.
transcribe rearranged V011 genes that are out-of-frame. Alternatively, some V011-
encoded /3 chains may not pairwith particular a chains to form surface heterodimers.
The expression ofV(3gene segments was alsodetermined in severalT cellhybrids
known to express the RR3-15 epitope. RNA was prepared from aT cell hybridoma
(KL) obtained by fusing the immunogen, OH6, with the rat thymoma, C58, and
from two other RR3-15+ T cell hybridomas (K12 and K13). It can be seen in Fig.
2 that all three RR3-15+ T cell hybrids transcribe the Va11 gene. These data, along
with those from Table III demonstrate that all 34 T cell hybridomas expressing a
surface molecule detected by the RR3-15 mAb transcribe the V011 gene. An ex-
ample of an RR3-15+ T cell line that does not express V011 RNA has not yet been
found. Since we have not exhaustively examined Va11+, RR3-15 - T cells, the pos-
sibility cannot be excludedthat theV011 domain does notexpress the RR3-15 deter-
minant inthe context ofcertain combinations ofVa,Ja, Do, orJ(3 segments. Neverthe-
less, the simplest interpretation ofthese datais that the RR3-15 determinant ispresent
on the V011 gene product and that all Voll-encoded TCRs express this epitope.
Strain K A
H-2
E D
Percent of peripheral
T cells expressing
Vol t
B10 b b - 6 4.6 + 0 .1
B10.M f f - f 4.5 f 0.1
B10.Q q q - q 6.3 ± 0 .5
B10.S (7R) s s - d 3.5 f 0.7
B10.D2 d d d d 1 .7 + 0 .8
1310.13R k k k k 0.7 1 0.1
B10.PL u u u u 0.2 0 .1
C57L b b - b 0 .04 + 0 .03
SWR q q - q 0.1
DBA/2 d d d d 1 .6 +_ 0.1
CBA/Ca k k k k 0.5 +_ 0.1
CBA/J k k k k 1 .2 ± 0.1
C3H/Hej k k k k 0.9 ± 0.1
(B10 x BlO.BR)Fl b/k b/k b/k b/k 0 .8 ± 0.1
BDFl b/d b/d b/d b/d 1 .3 + 0.1
B10 .A (4R) k k - 6 5 .0 ± 0.6
B10.A (2R) k k k b 0 .5 ± 0.3
B10 .A (3R) b b b/k d 1 .57
BlO.MBR b k k q 0.78, 0.59
BlO .TL s s/k k d 0 .56
B10.HTT s s s/k d 0.45TABLE III
RR 3-15 Expression Among Selected Hybridomas
TCR V region RNA expression was determined by hybridization with 32p-
labeled V-specific probes to V02-17 and Vat-8 and VotI0,11, and 13 as described
(23). HB, Q, and BR hybrids were derived from Con A-stimulated peripheral
T cells from 1310, B10.Q, and B10.13R mice, respectively. BBM hybridomas
were derived from B10 mice and are I-Abm12 reactive. Hybrids were stained
with labeled RR3-15 antibody and analyzed in an Epics C flow cytometer as
described in Materials and Methods. For Va expression, (-) indicates that the
hybridoma expresses RNA from the Val family or from a Va family for which
we have no probe.
Hybridoma VR Va RR 3-15
1 HB 27 11 3 -
1 HB 36 11 3 and 11 +
1 HB 88 11 3 +
1 HB 133 11 3 -
1 HB183 11 - +
1 HB 184 11 5 +
2 H B 49 11 3 and 8 +
3 HB 68 11 - +
3 HB 120 11 3 +
3 HB 123 11 4 and 13 +
4 HB 32 11 13 +
4 HB 40 11 3 +
4 HB 42 11 8 -
4 HB 56 11 4 +
4 HB 81 11 - -
4 HB 99 1 1 10 and 11 +
1Q11 11 - +
1 Q53 11 3 +
1 Q59 1 1 8 -
1 Q 62 il - +
2 Q 34 11 2 and 4 -
2 Q36 11 - +
3 Q39 11 - +
.3 Q 96 1 1 - +
4 Q 41 11 - +
5Q4 11 2and3 +
5 Q 5 11 2 +
5 Q 12 11 13 +
5 Q 65 1 1 4 +
5 Q68 11 4 +
5 Q 78 11 3 and 8 -
5 Q79 11 - +
5 Q 125 11 - +
1 BR 92 11 8 +
1 BR 168 11 5 and 13 -
2 BR 118 11 3 and 5 +
4 BR 10 11 3 +
4 BR 25 11 3 and 13 +
4 BR 37 11 10 +
2HB51 .8 5 10
4HB48.8 5 3 and 11
4Q53 .5 5 10
1Q16 .7 5 8
18BBM-4 8 -
17BBM52 8 3 and 8
lHB111 9 3
16BBM53 12 8
5Q26 13 3
2BR51 13 2BILL ET AL .
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FIGURE 2 . RR3-15' T cell hybrids
express V011 RNA . (1) KL, RR3-15' ;
(2) KI2, RR3-15' ; (3) KI3, RR3-15' ;
(4) 4Q53 .5, RR3-15- ; (5) 4HB 48 .8,
RR3-15- ; (6) 3HB19-control for V/311 ;
(7) 3HB51 control for V012 . 0 .5 Rg of
total cellularRNA from KL, K12, and
KI3 or 3 x 10 5 cell equivalents oftotal
cellular RNA from the other hybrids
were blotted onto nitrocellulose filters
which were hybridized with s 2P-la-
beled probes for Voll and V012 .
The Frequency of V011 + T Cells in Mice Is Dependent on theMHC Haplotype .
￿
To ex-
amine the effect of particularMHC haplotypes on the frequency ofV011' T cells,
we subjected lymph node T cells from a panel ofmouse strains to cytofluorographic
analysis using the RR3-15 mAb. The data in Table II show that 136 (H-2b), B10
(H-2b), B10.M (H-2), B10.Q(H-2q), and B10.S(7R) (H-2 1d) mice express the largest
fraction of Va11' T cells (3.5-6.3%) . On the other hand, the fraction ofVoll' T
cells in BMW (H-2d), B10.BR (H-2'), and B10.PL (H-2°) is significantly lower
(0.2-1.7%) . Other H-2d and H-2k strains (DBA/2, CBA/Ca, CBA/J, and C3H/HeJ)
have a relatively low frequency of V011-bearing T cells (0.5-1.6%) . The number of
V011' T cells in C57L (H-2b) and SWR (H-2q) mice is negligible (0.04-0.1%) .
Given that the V011 gene is deleted from thegenome ofthese two strains, these values
probably represent the true background in these cytofluorographic experiments .
Crossing a strain that carries ahigh frequencyofV011-bearingT cells with a strain
that carries a low frequency of V011-bearing T cells produces F1 mice that express
a low frequency ofVa11'T cells (see Table II) . The frequency ofT cells with V(011-
encoded TCRs in [B10 x B10.BR]Ft mice (0.8%) is similar to that seen in B10.BR
mice (0.7%) . Similarly, the frequency of V011' T cells in [B6 x DBA/2]Ft mice
(1.3%) is similar to that seen in DBA/2 mice (1.6%) . Thus, the phenotype of infre-
quent expression ofV011'T cells is dominant, relative to the phenotype of frequent
expression ofVa11' T cells in F1 mice. Considering that the frequency of T cells
with Voll-encoded antigen receptors is low in [B10 x B10.BR]F t mice, it is likely
that a protein encoded buy theMHC of B10.BR (H-2k) mice is depressing the level
of V011' T cells . To examine this point further, we compared the expression of
Voll-bearing T cells in MHC recombinant mice, and the most relevant MHC-
recombinant strains are B10.A(4R) and B10.A(2R) . The frequency of V011' T cells
is high (5 .0%) in B10.A(4R) but low (0.5%) in B10.A(2R) mice, yet the only genetic
difference between these two strains is that B10.A(2R) mice express an I-E protein
while B10.A(4R) mice do not . Thus, is seems likely that the majority ofT cells ex-
pressing theV011 domain as part oftheirsurface antigen receptor areclonally deleted
in I-E-bearing mice . Consistent with this idea is the fact that the frequency ofVOW
T cells is generally high in mice that carry I-E - haplotypes (H-2b,f s[7R], and q)
but generally low in mice that carry I-E' haplotypes (H-2d, -k, and -u) .
Mature V011' Thymocytes Are Absentfiom I-E-bearingMice.
￿
We examined the Voll-
bearing thymocytes in young adult B10.A(4R) (I-E -), B10.A(2R) (I-E'), and C57L
(V011 gene-deleted) mice . Asshown in Fig. 3, Voll thymocytes expressing low levels
ofTCR (RR3-15 dull cells) are present in B10.A(4R) (I-E-) and in B10.A(2R) (I-E')1412
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￿
Absence
of Voll expres-
sion
among mature but not immature
RR3-15
￿
thymocytesinI-E+mice.
Fluorescence
anti-Vp
11 ￿
histograms
ofthymcytes from B10
.A(2R)
and
B10
.A(4R)
or, as a negative con-
trol,
C57L adult mice
.
RR3-15 and
RR4-7
were biotinylated and phyco-
erythrin-conjugated
streptavidin was
used
as a secondary staining reagent
.
RR3-15
￿
Indicated
percentages of V1311' T cells
anti-Vp
11 ￿
were
obtained by curve subtraction
.
Dashed
lines indicate staining by sec-
ondary
reagent alone
.
Thymocytes
were
cultured for 8 h before staining
to
increase the level of TCR on imma-
ture
cells as described (14)
.
mice;
however, V011+ thymocytes expressing high levels of TCR (RR3-15 bright
cells)
are present only in B10
.A(4R)
(I-E-) mice
.
As expected, both RR3-15 dull and
RR3-15
bright cells are absent from C57L (V011 gene-deleted) mice
.
As a control,
thymocytes
from C57L mice were stained with an mAb, RR4-7 (17), specific for
the
V(06 gene product
.
Clearly, V06' thymocytes (TCR dull and bright) are present
in
this strain
.
Thymocytes with low levels ofsurface TCRs are characteristically double
positive
(CD4+ and CD8+), cortical, and functionally immature, while thymocytes
with
high levels of surface TCRs are characteristically single positive (CD4+ or
CD8+),
medullary, and functionally mature (31)
.
Our findings suggest that the pres-
ence
of I-E prevents the appearance of the majority of V011+ mature thymocytes
and
V011+ peripheral T cells
.
Most
V011' Hybridomas Are not Reactive with I-E-bearing Splenocytes
.
￿
Since
I-E
mediates
the clonal deletion of VOW T cells, we have studied the reactivities of 25
T
cell hybridomas that express Va11-encoded surface receptors
.
These hybrids were
stimulated
with I-El-bearing splenocytes or CH12 (I-E') lymphoma cells
;
surpris-
ingly,
we found only three (12%) that could be stimulated to produce IL-2
.
That
all
25 hybrids were capable of IL-2 production was demonstrated by their response
to
stimulation with the antiVoll antibody, RR3-15 (data not shown)
.
Since it is
possible
that the I-E reactivity of V011+ hybridomas is dependent on the presence
of
surface CM molecules, we have studied a set of six V011+ hybrids that express
CD4
surface molecules (see Table IV)
.
All six hybridomas secrete IL-2 when stimu-
lated
with a crosslinked form of the antiTCR antibody, RR3-15, yet only one hybrid
(5Q5)
can be stronlgy stimulated with I-E-bearing splenocytes from B10
.BR
(I-Ek)BILL ET AL.
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TABLE IV
Specificity of CD4+ V,l311+ T Cell Hybridomas
or B10.D2 (I-Ed) mice . Given the Conal deletion of N90% of V011+ T cells from
I-E'-bearing mice (see Table II and Fig . 3), the rarity of V011+ hybridomas reac-
tive with I-E'-bearing splenocytes seems paradoxical .
TheMHCMolecule I-E Is Necessary but not Sufficient to Mediate the Clonal Deletion of
Vol]-bearing TCells . To confirm that the regulation of the number ofV#11+ T cells
is mediated by MHC-encoded proteins, the frequency of V011+ cells was deter-
mined in 23 C57BL/6 x DBA/2 (BXD) recombinant inbred (RI) 1 strains . All loci
in these strains are either B6 or DBA/2 in origin ; consequently, theMHC in each
of these strains is either H-2b (B6-derived) or H-2a (DBA/2 derived) . The data in
Fig . 4 show the frequency ofV011 + T cells in these RI strains . The level of V011-
bearing T cells in each strain is quite reproducible in that the SEM of these mea-
surements is small relative to the total fraction of V011 + cells . Thus, the frequency
ofV011+ T cells represents a reproducible phenotype in each of these strains . Con-
sidering the H-2b (I-E-) strains, the frequency of V011-bearing cells is high
(-5.5%), consistent with the absence ofConal deletion in I-E- mice . On the other
I Abbreviations used in this paper: RI, recombinant inbred .
FIGURE 4 .
￿
Frequency ofV011-bearing
T cells in 23 strains of C57BL/6 x
DBA/2 RI mice . The frequency of
V311'T cells was determined as de-
scribed in the legend to Fig .3. Formost
of the strains, the values in the figure
represent the average of at least three
animals . TheSEM is indicatedby the
error bars . For stains 27, 28, and 29,
only two animals were analyzed, and
consequently, the SEM could not be
calculated . The frequency ofV011'T
cells was 3.2%, 3.7% for strain 27 ;
3.6%, 3.8% for strain 28 ; and 5.4%,
5.9% for strain 29 . C57BL/6, DBA/2,
and (C57BL/6 x DBA/2)FI mice
carry 5 .6 ± 0.2%, 1.6 ± 0.1%, and 1.3
± 0.1% V011' T cells, respectively.
Hybridoma
IL-2
RR3-15
(anti-VO11)
released when stimulated with:
B10.BR(H-2k) B10.D2(H-2d
)
splenocytes splenocytes
expression
Vol I
Surface
CD4
U
IHB36 640 <10 <10 + +
1HB184 160 <10 <10 + +
3HB123 320 <10 10 + +
4HB56 320 <10 10 + +
5Q4 80 10 10 + +
5Q5 640 160 20 + +1414
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hand, the frequency of VOW T cells varies considerably among the H-2d (I-E+)
strains. Some I-E+ strains (Nos. 6, 9, and 16) carry a small fraction (-0.8%) of
Volt' T cells, while other I-E+ strains (Nos. 25, 27, and 28) carry a much larger
fraction (N3.5%) ofVolt' Tcells. To rule out the possibility that these differences
are due to quantitative differences in the degree of I-E expression between these
strains, the amount of the I-E gene product was measured on lymph node B cells
from several RI strains (Nos. 6, 9, 11, 18, 21, 24, and 25) that carry different levels
ofVolt' T cells (data not shown). The amount ofI-E expressed on the surface of
B cells in several ofthese RI strains is virtually identical. Thus, the variation in the
frequency of Volt' T cells among I-E+, BXD RI strains cannot be explained by
quantitative differences in the expression of the I-E gene product.
Discussion
We have identified an mAb that recognizes a determinant on all or nearly all T
cells expressing theVolt domain as part oftheTCR. Basedonthe followingcriteria,
the antibody, RR3-15, recognizes an epitope encoded by the Volt gene segment.
RR3-15 precipitates a 90-kD heterodimer, characteristic of the TCR, from the im-
munizing T cell clone OH6. RR3-15 mediates the lysis of P815 cells by OH6
(Volt') but not by another (V08.1+) T cell clone, OH2. Of 34 T cell hybridomas
that express the RR3-15 determinant all transcribe the Volt gene segment (Table
III and Fig. 2). RR3-15+ T cells are undetectable in SWR and C57L mice (see
Table II); these strains carry an allele ofthe /3 chain gene complex that has deleted
the Volt structural gene (27, 28). Of 10 T cell hybrids expressing V05, V08, V/39,
Va12, or V013 RNA, none express a surface molecule recognized by the RR3-15
mAb. This is notable since SWR and C57L mice are deleted for these V(3 genes
as well. Taken together, these data strongly suggest that the TCR determinant rec-
ognized by the mAb, RR3-15, is part of the Volt domain. It is expected that an
epitope encoded by a single V(3 gene would be present on N5% of T cells as there
are 21 functionalV(3 gene segments in mice. Since N5% ofT cells from B10, B10Q,
and B10.M mice are RR3-15+, it seems likely that expression ofVolt gene is both
necessary and sufficient for the expression this epitope. However, we can not rule
out the possibility that some combinations ofVcx, Ju, D(3, andJ(3 genes segments
donot permit theexpression ofthe RR3-15 determinant onafewVo11-encoded TCRs.
The most striking aspect ofour findings is that a majority ofT cells with Volt-
encoded antigen-receptors are clonally deleted from I-E-bearing mice. In general,
the frequency ofVolt' Tcells is much lowerin I-E-bearing mice than it is in strains
that do not express a functional I-E protein (see Table II). The most dramatic ex-
ample of this effect can been seen when comparing the frequency ofVolt' T cells
in B10.A(4R) and B10.A(2R) mice. These two strains share the same genetic back-
ground (B10) and the same H-2K, H-21-A, and H-2D genes; however, they differ
intheirexpression ofthe I-E geneproduct (32). B10.A(4R) mice are geneticallydefec-
tive in their expression of an I-E gene product and 5% of their T cells express a
Voll-encoded TCR. Onthe otherhand, B10.A(2R) mice expressthe I-E geneproduct
but only 0.5% oftheir T cells express a Vo11-encoded TCR (see Table II). Thus,
the frequency of Volt' T cells is inversely correlated with the presence of an I-E
molecule. The effect of I-E is genetically dominant in that F1 mice derived from
I-E-expressing and I-E-nonexpressing parents express I-E and clonally delete theBILL ET AL.
￿
1415
majority of their VM1' T cells (see Table II). A comparison of the frequency of
V011' T cells in B10.D2(I-Ed), BIO.BR(I-Ek), B10.PL(I-E°), B10.A(3R)(I-Eb), and
B10.HTT(I-E') mice indicates that most if not all alleles of the I-E locus are capable
(to varying degrees) of deleting V011' T cells from the repertoire. The elimination
of V011' T cells encompasses both the CD4' and CD8' subsets, though the elimi-
nation of CD4+ cells is more dramatic (data not shown). Two closely related but
I-E-disparate strains, B10.A(2R) (I-E') and B10.A(4R) (I-E-), were examined for
the expression of V011 on both mature and immature thymocytes (Fig. 3). Both
strains contained immature thymocytes expressing the VQ11 domain; however, in
B10.A (4R) (I-E-) but not in B10.A(2R) (I-E') mice, there were thymocytes ex-
pressing high density V011' TCRs. Thus, the clonal deletion of V011' T cells ex-
tends to mature thymocytes in I-E' mice.
Thesefindings areremarkably similarto those reported to Kappleret al. (13, 14).
They have determined that T cells bearing antigen receptors encoded by the V017a
gene segment are clonally deleted from I-E-bearingmice. They have furtherdemon-
strated that mature (high density TCR) V017a' thymocytes are absent from strains
expressing I-E and that all I-E alleles examined mediate the clonal elimination of
V017a' T cells (14). These properties apply to V011' T cells as well. Given that all
allelic forms of the I-E protein mediate the clonal deletion of both V011' and
V017a' T cells, it seems likely that these cells recognize an epitope that is common
(public determinant) to all polymorphic forms of I-E. However, allelic differences
between I-E molecules may determine the extent of clonal deletion. For example,
I-Ek deletes a larger fraction of V011' and V017a' T cells than does I-Ed (Table
II and reference 33).
One striking difference between V011 and V017a-encoded TCRs is that a large
fraction (ti90%) of V017a' hybridomas are strongly reactive to I-E when stimu-
lated with I-E-bearing splenocytes or lymphomas (13). We have examined 25 V011'
hybrids fortheir reactivity to I-E when stimulated with B10.BR (H-2k) spleen cells
or CH12(H-2k) lymphoma cells and found only three potentially I-E-responsive hy-
bridomas (datanot shown). Since all 25 hybrids respond when theirantigen receptors
are crosslinked with the antiVo11 reagent, RR3-15, these hybrids have V011' sur-
face TCRs and are capable of secreting IL-2. Furthermore, we have examined six
ofthese hybrids that expressCD4 surface moleculesand found only one to be poten-
tially I-E reactive (see Table IV). Thus, it is difficult to argue that the absence of
CD4 accessory molecules accounts for the lack of pronounced I-E recognition in
most of these V011' hybrids. The explanation for the lack of I-E recognition by
hybrids bearingV011-encoded TCRs maybe trivial. It is conceivable that theaffinity
of a V011' TCR for the I-E ligand is low (accounting for the lack of I-E reactivity
among V011' hybrids) but that the in vivo clonal deletion of V011' T cells requires
only a weak interaction between the TCR and I-E. A second, perhaps more intrig-
uing, hypothesis to explain this discrepancy is that splenocytes, although I-E bearing,
do notpresent the actual ligand forV#11-encoded TCRs and arenot the tolerogenic
cells in the mouse. This could be the case, if the actual ligand for V011' T cells
is an I-E molecule plus a self-peptide. This protein fragment may not be produced
by splenocytes but is expressed by other I-E-bearing cells that mediate the clonal
deletion. This idea has been proposed recently (34) and experiments are underway
to resolve this issue.1416
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The idea that the tolerizing ligand(s) for V011 + cells is an I-E/self-peptide com-
plex is further supported by experiments examining the frequency of V011' cells
in C57BL/6 x DBA/2 (B xD) RI mice (see Fig. 4). All RI strains that carry the
H-2b (I-E-) haplotype have a full complement of V011 + T cells, demonstrating the
lack of clonal deletion in the absence of I-E expression. On the other hand, the de-
gree of clonal deletion of Voll-bearing T cells is not equivalent in all H-2d(I-E+),
Bx D RI strains even though the magnitude of I-E expression among these H-2d
strains is similar. Some RI strains (Nos. 6, 9, and 16) show a strong deletion of
V,611+ T cells, while other RI strains (Nos. 18, 25, 27, and 28) display a much
weaker elimination of Voll-bearing T cells (see Fig. 4). Other RI strains display
intermediate levels of clonal deletion. Taken together, these resultsdemonstrate that
expression of the class II molecule, I-E, is necessary but not sufficient to mediate
the clonal deletion of V011+ T cells. It is likely that some genes in the B6 genetic
background and other genes in the DBA/2 genetic background complement the I-E
genes to mediate the clonal deletion of V011+ T cells. Furthermore, it is the segre-
gation ofthese genesthat most likely accounts forthe varied extent of clonal deletion
amongtheseB x D RI strains. These background genes possibly encode self-proteins
that generate peptides with I-E-bindingproperties. Theimplicationof these findings
is that the products of genes other than I-E control the extent of clonal deletion.
Given the plethora of V/3 domains that impart reactivity to I-E, Mls-1 or Mls-2
gene products (13, 15, 16, 17, 30), we have wondered whether VR or Va domains
exist that confer a generic reactivity to H-2 K, I-A, or D glycoproteins . In retro-
spect, it has been relatively easy to identify TCRs that are clonally deleted in the
presence of I-E proteins because of theexistence of I-E-expressing and nonexpressing
strains of mice. Since no strains have been described that are nonexpressors of the
H-2 K, I-A, or D gene products, it is experimentally difficult to identify these kinds
of TCR domains. Nevertheless, it seems unlikely that V region domains exist that
are pan-reactive with H-2 K, I-A, or D gene products becauseof enormous pressure
against maintaining such V genes in the germline. A V domain that imparts reac-
tivity for a gene product expressed in every member of a species and somatically
eliminated from the repertoire would offer no protective value and be of no advan-
tage to the organism nor to the species. In this context, it is conceivable that the
V011, V017, V08.1, V06, and V03 TCR domains have evolved to have ahigh affinity
for their ligands (I-E, Mls-1, Mls-2), because these ligands are not ubiquitously ex-
pressed in all mice.
The selective pressure to maintain V genesencoding self-reactive domains should
be weak or nonexistent and the sequence of these genes might drift resulting in the
appearance of pseudogenes. The V017b gene provides an illustration of this point.
This V017 allele carried by most strains of inbred mice is nonfunctional due to the
presence of a termination signal at codon 88 (35). Since V017a-encoded receptors
are presumably eliminated from a large proportion of outbred mice, the selective
pressure to maintain this V(3 gene is weak. Thus, it is not surprising that one of
the V017 alleles has drifted and become a pseudogene.
We have previously observed a decrease in the frequency of V011 + T cells from
B10.BR (I-E+) mice. By analyzing the RNA from large panels of random T cell hy-
bridomas for the expression of 16 V(3 and 10 Vu gene families (23), we determined
the frequency with which these V gene families are expressed among T cells fromBILL ET AL.
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three MHC congenic strains. From this analysis, we noticed a statistically significant
decrease in the frequency of V011-expressing hybrids in B10.BR (I-E'') compared
with B10 (I-E-) and B10.Q(I-E-) mice. The cytofourographic experiments described
here with the antiVo11 reagent, RR3-15, have independently confirmed our previous
observations.
Our analysis ofV gene expression among MHC congenic strains (23) also reveals
a low frequency of T cells expressing the V05.1, V05.2, and V012 gene segments
in B10.BR (I-E+) mice relative to B10 (I-E-) and B10.Q(I-E -) mice. It is at least con-
ceivable that T cells bearing these V0 domains are clonally deleted from I-E+ mice
as well. Thus, an I-E-bearing mouse may lose up to 20% (4 of 20 V(3 domains)
of its TCR repertoire due to the somatic deletion of I-E-reactive T cells. While this
is costly, in terms ofthe size ofthe repertoire, a mouse that expresses I-E has another
MHC protein that can present antigens and can positively select (I-E-restricted)
T cells. On balance, I-E + and I-E- haplotypes may generate equally protective cell-
mediated immunity.
Summary
We have generated an mAb, RR3-15, that recognizes murine TCRs containing
the Voll domain. Using this antibody to stain peripheral T cells, we have demon-
strated that V911-bearing T cells are largely absent from strains ofmice that express
the class II MHC molecule, I-E. Studies with Fl mice demonstrate that this effect
is dominant, consistent with tolerance. The clonal deletion of Vo11-bearing T cells
appears to occur intrathymically, as immature but not mature Vo11+ T cells are
present in the thymus of I-E-bearing mice. Examination of B6 x DBA/2 recom-
binant inbred strains demonstrates that the expression of I-E molecules is necessary
for the clonal deletion ofVfll-bearing T cells, but that other non-MHC genes con-
trol the clonal deletion process, as well. Paradoxically, only a small fraction of V011
T cell hybridomas are I-E reactive.
Receivedfor publication 27 October 1988 and in revisedform 9 December 1988.
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